Efficacy and safety of vixotrigine in idiopathic or diabetes-associated painful small fibre neuropathy (CONVEY): a phase 2 placebo-controlled enriched-enrolment randomised withdrawal study

BACKGROUND: No pharmacological treatments are specifically indicated for painful small fibre neuropathy (SFN). CONVEY, a phase 2 enriched-enrolment study, evaluated the efficacy and safety of vixotrigine, a voltage- and use-dependent sodium channel blocker, in participants with idiopathic or diabete...

Descripción completa

Detalles Bibliográficos
Autores principales: Faber, Catharina G., Attal, Nadine, Lauria, Giuseppe, Dworkin, Robert H., Freeman, Roy, Dawson, Katherine T., Finnigan, Helen, Hajihosseini, Amirhossein, Naik, Himanshu, Serenko, Michael, Morris, Christopher J., Kotecha, Mona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154969/
https://www.ncbi.nlm.nih.gov/pubmed/37152360
http://dx.doi.org/10.1016/j.eclinm.2023.101971

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154969/
https://www.ncbi.nlm.nih.gov/pubmed/37152360
http://dx.doi.org/10.1016/j.eclinm.2023.101971

Ejemplares similares